Ionis Pharmaceuticals, Inc.
IONS
$72.33
-$0.01-0.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 29.74% | -65.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 29.74% | -65.33% | |||
| Cost of Revenue | 30.67% | -0.69% | |||
| Gross Profit | -32.98% | -127.50% | |||
| SG&A Expenses | 34.48% | 6.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.84% | 1.50% | |||
| Operating Income | -33.88% | -214.57% | |||
| Income Before Tax | -77.51% | -203.94% | |||
| Income Tax Expenses | 593.90% | 1,165.00% | |||
| Earnings from Continuing Operations | -78.37% | -204.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -78.37% | -204.09% | |||
| EBIT | -33.88% | -214.57% | |||
| EBITDA | -33.86% | -210.25% | |||
| EPS Basic | -75.90% | -203.68% | |||
| Normalized Basic EPS | -42.47% | -211.16% | |||
| EPS Diluted | -75.90% | -215.00% | |||
| Normalized Diluted EPS | -42.47% | -227.38% | |||
| Average Basic Shares Outstanding | 1.40% | 0.39% | |||
| Average Diluted Shares Outstanding | 1.40% | -12.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||